BioSpace News Archive

National Health Investors, Inc. provided a business update regarding its monthly contractual cash collections.

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021, at 1:30 PM EDT.

Leucadia Pharmaceuticals, a U.S. leader in generic injectables and the commercial arm of Custopharm, Inc., today announced the launch of its latest FDA-approved generic, Calcitonin Salmon Injection, USP, Synthetic.

Meiji Seika Pharma Co., Ltd. announced that the bioequivalence of DMB-3115, a proposed ustekinumab biosimilar, has been demonstrated in phase I clinical trial compared to the reference products marketed in Europe and the United States.

Validant, a leading global quality, compliance and regulatory consulting group, has acquired Clinical Outcomes Solutions (“COS”), a global leader in clinical outcomes assessments (COA).

Geisinger has been named runner-up out of more than 300 entries in the Centers for Medicare & Medicaid Services (CMS) Artificial Intelligence Health Outcomes Challenge.

The new business is uniquely positioned to continue delivering research solutions for COVID-19 and beyond with community presence, data capabilities and health care expertise

Codagenix Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, and Univercells S.A., a global life sciences company using bioprocessing expertise and next-generation technologies to open access to bioproduction, today announced a research collaboration agreement on an undisclosed

The Feinstein Institutes for Medical Research, the science arm of Northwell Health, has named Lopa Mishra, MD, co-director for the Institute of Bioelectronic Medicine.

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from diseases, today announced it will participate in the M-Vest Virtual Conference Series: Alzheimer’s Disease Panel on Wednesday, May 26, 2021 at 11:00 AM ET.